510(k) Report

510(k) · Cleared

Cleared

Lacrytest

K034057510(k) TraditionalCleared Mar 9, 200470-day reviewClass II21 CFR 866.5510

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Adiatec SA · DGC Ige, Antigen, Antiserum, Control

Cleared on Mar 9, 2004 as substantially equivalent to K964152 (Pharmacia, Inc., 1997) after a 70-day review. Its family tree reaches back 1 generation to 1997.

Decided
Mar 9, 2004
Review
70 days
Class
Class II
Product code
DGC
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K964152 (1997). No later device cites it as a predicate yet.

K964152 · Unicap Total Ige Assay/Pharmacia Total Ige Controls LMH · Pharmacia, Inc. · 1997199619982000200220042006
  1. Root · 1 generation backK964152 Unicap Total Ige Assay/Pharmacia Total Ige Controls LMHPharmacia, Inc. · 1997
  2. This deviceK034057 LacrytestAdiatec SA · 2004
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K964152Unicap Total Ige Assay/Pharmacia Total Ige Controls LMHPharmacia, Inc.1997—
0 (this device)K034057LacrytestAdiatec SA2004—
FIG. 1 — Lineage of K034057, 1997–2004Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DGC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DGC device

  1. #1 K231151 Kenota 1 Total IgE; Kenota 1 (instrument)score 8.0 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K964152Unicap Total Ige Assay/Pharmacia Total Ige Controls LMH
Summary page 1
…NTIGEN, ANTISERUM, CONTROL Regulation Number 866.5510 510(K) Number K964152 Device Name UNICAP TOTAL IGE ASSAY/PHARMACIA TOTAL I…
Pharmacia, Inc.1997—

Also cleared against K964152: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 2 other devices also cite its predicate K964152.

How does its category compare?

All DGC devices

DGC Ige, Antigen, Antiserum, Control: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DGC

1in 2024

2007: 12014: 12016: 12020: 12022: 12023: 12024: 1
2007high 1 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DGC

Too few DGC 510(k)s in any year since 2007 to give a median.

Recalls per year · DGC

1in 2016

2009: 12016: 1
2007high 1 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DGC

2in 2021

2008: 22009: 52010: 122011: 132013: 12014: 12015: 22016: 22021: 2
2007high 13 (2011) · low 0 (2007)2025

MAUDE reports naming product code DGC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—02
20090—15
20100—012
20110—013
20120—00
20130—01
20141—01
20150—02
20161—12
20170—00
20180—00
20190—00
20201—00
20210—02
20221—00
20231—00
20241—00
20250—00
20260—0—

What is it indicated for?

Lacrytest is a rapid immunoassay for the detection of total IgE in tears. Semi-quantitative detection of total IgE in tears (< 2.5 klU/Iiter, 2.5 - 10 klU,qiter, 10 - 40 klU/liter, and > 40 klU/liter) indicates local IgE production associated with allergic conjunctivitis. This test is used in the physician office and professional clinical laboratories.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K034057: Lacrytest.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K034057

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026